Mediaiplus is a brand that specializes in curating data for clients preparing for clinical trials. Their aim is to expedite the preparation process, ultimately helping new treatments reach patients faster and saving more lives. With a carefully designed clinical trial plan, Mediaiplus provides clients with vital information and data analysis to make well-informed decisions at each phase of the trial.

They strive to make drug development more efficient, ultimately benefiting pharmaceutical companies, researchers, institutions, and new drug development efforts. Mediaiplus envisions being the number one global clinical trials matching and custom information platform. They achieve this through the integration of publicly available clinical data and the provision of a professionally curated database to create valuable clinical trial information.

By using AI algorithms, they match Korean and global clinical trials information, improve Korea's clinical competitiveness, and offer stakeholders like pharmaceutical companies and researchers customized subscription and notification services. Mediaiplus is committed to leveraging data to protect people's right to health